Xcout Intel
Cardiosense, Inc.
Cardiosense, Inc. is a Chicago-based digital health company that leverages artificial intelligence and multi-sensor devices. It recently completed a $15.1 million Series A financing round to advance its medical technology solutions.
Subscribe to see Cardiosense, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cardiosense, Inc. at a glance
Cardiosense, Inc. is a medical technology company headquartered in United States. Its most recent funding round raised $26.1M in August 2026. Xcout tracks 14 named people at Cardiosense, Inc., including Eric Meizlish (Chief Executive Officer).
Cardiosense, Inc. leadership
- Eric MeizlishChief Executive Officer
- Arezou Azar, PhDChief Regulatory & Compliance Officer
- John D. Martin, MD, MBA, FACSChief Medical Officer
- Andrew Carek, PhDCo-founder, Chief Technical Officer
- Omer Inan, PhDCo-founder, Chief Scientific Officer
- Mozziyar Etemadi, MD, PhDCo-founder, Head of AI
8 more named people on record for Cardiosense, Inc., with roles, board committees and tenure — see the full roster →
Cardiosense, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $26.1M | — | |
| SEC Form D filing | $9.1M | — | |
| Series A | $15.1M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Cardiosense, Inc. competitors
A few of Cardiosense, Inc.'s closest competitors — see the full list of competitors and alternatives →
Eko Health is a U.S. digital health company that develops smart stethoscopes and clinical software using artificial intelligence to help detect heart and lung conditions. Its products are intended for healthcare professionals, including primary care clinicians and cardiologists.
Child Health Imprints develops IoT devices, artificial intelligence, and predictive analytics software for neonatal intensive care units. Its products automate clinical workflows, capture real-time vital signs, predict neonatal diseases prior to clinical manifestation, and track child health development post-discharge.
Cordio Medical develops medical-grade remote monitoring solutions that analyze voice samples through a smartphone application to detect health condition deterioration in near real-time. Its primary product, the Cordio HearO, uses mobile speech analysis to sense fluid accumulation associated with congestive heart failure and alerts healthcare professionals to early clinical decompensation.
Cardiologs is a medical technology company headquartered in Paris, France, acquired by Philips Healthcare. It is on a mission to democratize expert cardiac care using medical-grade artificial intelligence, employing a team largely composed of software engineers and data scientists.
Impact Vitals is a digital healthcare and medical technology company that develops artificial intelligence-based solutions to transform physiologic data into vital signs for patient monitoring. The company provides software and tools designed to help caregivers detect early patient deterioration and improve clinical outcomes in hospitals.
CIPRA.ai is a digital health company headquartered in San Diego, California. The company leverages artificial intelligence to deliver personalized health recommendations and management tools for conditions such as hypertension and diabetes.
Get Cardiosense, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cardiosense, Inc. in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access